In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa-Reference-Cited by-同舟云学术

In Vitro Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa

Published:2021-08-17 Issue:9 Volume:65 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Maphanga Tsidiso G.¹^ORCID,Naicker Serisha D.¹²,Kwenda Stanford³,Muñoz Jose F.⁴^ORCID,van Schalkwyk Erika¹,Wadula Jeannette⁵,Nana Trusha⁶,Ismail Arshad³^ORCID,Coetzee Jennifer⁷,Govind Chetna⁸,Mtshali Phillip S.³,Mpembe Ruth S.¹,Govender Nelesh P.¹²⁹^ORCID

Affiliation:

1. National Institute for Communicable Diseases, Centre for Healthcare-Associated Infections, Antimicrobial Resistance, and Mycoses, National Health Laboratory Service, Johannesburg, South Africa

2. School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

3. National Institute for Communicable Diseases, Sequencing Core Facility, National Health Laboratory Service, Johannesburg, South Africa

4. Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA

5. National Health Laboratory Service, Chris Hani Baragwaneth Academic Hospital, Soweto, South Africa

6. National Health Laboratory Service, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa

7. AMPATH National Laboratory Service, Centurion, South Africa

8. Lancet Laboratories, Durban, South Africa

9. Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

Abstract

Candida auris is a multidrug-resistant fungal pathogen that is endemic in South African hospitals. We tested bloodstream C. auris isolates that were submitted to a reference laboratory for national laboratory-based surveillance for candidemia in 2016 and 2017.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00517-21

Reference38 articles.

1. Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species

2. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009–17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance

3. Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016–20171

4. Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values

5. Centers for Disease Control and Prevention. 2020. Antifungal susceptibility testing and interpretation. https://www.cdc.gov/fungal/candida-auris/c-auris-antifungal.html. Accessed 14 December 2020.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antifungal activity of synthetic xanthenone against fluconazole-resistant Candida auris and its mechanism of action;Microbial Pathogenesis;2024-09

2. Emergence of the novel sixth Candida auris Clade VI in Bangladesh;Microbiology Spectrum;2024-07-02

3. Evaluation of the Vitek 2 system for antifungal susceptibility testing of Candida auris using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance;Journal of Clinical Microbiology;2024-04-10

4. Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11;Mycoses;2024-03

5. Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?;Expert Review of Clinical Pharmacology;2024-02-21